An advanced clinical reasoning engine designed to support precise histopathological diagnostics. Equipped with specialized diagnostic support for lesions of the labial mucosa, including Mucus Extravasation Phenomena, Retention Cysts, and Irritation Fibromas.
Blending clinical expertise with advanced 3D printing and AI technology to improve patient outcomes globally.
The world's first clinical Delta 3D Bone Graft Printer. OsseoCraft delivers unmatched precision and sterility for osteoconductive bone grafts, reducing reliance on traditional titanium graft materials that can weaken surrounding tissues.
Spearheading innovative medical technology projects ranging from the proprietary OsseoMorph filament devices to sustainable dental gypsum waste recycling plants.
Celebrating milestones and breakthrough achievements at Pionomed Biogenix.
Pionomed Biogenix continues to set new standards in the medical innovation landscape. Recognized globally for our commitment to precision, sterility, and accessibility, our journey reflects a deep dedication to transforming healthcare and pioneering advanced reconstructive solutions.
Read the full story →"Each graft produced by Pionomed Biogenix is customised to meet the unique requirements of individual patients, eliminating the need for on-table modification and significantly improving surgical outcomes."
Read Full ArticleProudly showcasing the honors and accolades that validate our innovative journey.
Recognized for outstanding achievements and pioneering solutions presented at the prestigious MSigma Gokulam.
Honored as lead winners, demonstrating exceptional innovation and transformative potential in healthcare technology.
Recipient of the prestigious Charaka Award, acknowledging profound impact and dedication in advancing medical science.
Celebrating the remarkable achievements of our team as Nova 2023 Winners, pushing boundaries and redefining excellence.
Based in Thiruvananthapuram, Kerala, Pionomed Biogenix was founded by Dr. Adersh G.A. and Dr. Shivadhath R.P. Our mission is to push the boundaries of maxillofacial and reconstructive surgery by developing proprietary, cost-effective AI tools and biocompatible 3D printing technologies that make advanced care accessible to all.